Department of Interventional Therapy

The SYSMH is the earliest university-affiliated teaching hospital in the province to implement interventional therapy. The Interventional Radiology Subspecialty was officially established in September 2001 and serves as a subspecialty of the hospital’s National Key Clinical Development Discipline in Oncology and the Guangdong Provincial Key Clinical Discipline in Medical Imaging. Led by the renowned interventional expert Professor Xu Linfeng, the department comprises a high-level professional team primarily composed of medical doctors and master’s degree holders, supported by a comprehensive medical system that includes an interventional outpatient clinic, interventional ward, and interventional operating rooms. To date, the department has introduced various advanced interventional treatment technologies at both domestic and international levels. The unit currently operates 30 open beds and employs 10 full-time physicians. It is equipped with a comprehensive range of state-of-the-art minimally invasive interventional devices for tumor treatment, including microwave, radiofrequency, argon-helium cryoablation, nanoknife, radioactive particle implantation, tumor ablation planning navigation systems, and precision tumor embolization navigation systems. The department excels in managing complex cases, and its comprehensive interventional therapy for solid tumors is nationally recognized as advanced.
  Over the past five years, the Department of Interventional Therapy has led or participated in five scientific research fund projects, authored or co-authored fifteen monographs, obtained four national invention patents and five utility model patents. It has published over 100 papers on related basic and clinical research, including more than 30 SCI-indexed articles. The department has also contributed to the compilation of interventional teaching materials for undergraduate and postgraduate medical education. Collaborative research conducted by the department has been awarded the Second and Third Prizes for Scientific and Technological Progress of Guangdong Province.
  The Department of Interventional Therapy primarily performs interventional treatments for the following categories of diseases:
  1.Neoplastic Diseases:Malignant tumors, including liver cancer, lung cancer, cholangiocarcinoma, pancreatic cancer, bladder cancer, and gynecological cancers, treated with embolization chemotherapy, perfusion chemotherapy, microwave/radiofrequency/argon-helium cryoablation/nanoknife ablation, radioactive seed implantation, and comprehensive interventional therapies integrating targeted and immunotherapies.
Benign tumors, including hepatic hemangioma, renal angiomyolipoma, uterine fibroids, adenomyosis, and benign prostatic hyperplasia, treated with interventional techniques.
  2.Vascular Diseases:Angiographic diagnosis, embolization, thrombolysis, balloon angioplasty, and stent placement for vascular stenosis, occlusion, aneurysms, arteriovenous malformations, etc., due to various causes. This includes ischemic cerebrovascular diseases (carotid artery stenosis, vertebrobasilar artery stenosis, intracranial artery stenosis, endovascular thrombectomy for stroke), thoracic and abdominal aortic aneurysms, renal artery stenosis, deep vein thrombosis of the lower extremities, and peripheral arterial occlusive diseases (atherosclerosis, diabetic foot).
  3.Hemorrhagic Diseases:Arterial or venous gastrointestinal bleeding (hematemesis, melena), including comprehensive interventional treatments for portal hypertension (balloon angioplasty, venous stenting, second hepatic porta reconstruction, percutaneous transhepatic coronary/left gastric vein embolization, transjugular intrahepatic portosystemic shunt [TIPS], balloon-occluded retrograde transvenous obliteration [BRTO], partial splenic embolization [PSE]). Massive hemoptysis caused by pulmonary diseases.Hemorrhage of solid organs (liver, spleen, kidney, etc.) due to various causes, as well as refractory epistaxis.
  4.Non-vascular Diseases:Benign or malignant esophageal/tracheal stenosis and esophageal fistula, benign or malignant biliary obstruction (obstructive jaundice), ureteral strictures, intervertebral disc herniation, and fallopian tube stenosis.
  5.Hyperfunctional Organ Diseases:Hypersplenism due to cirrhosis, hyperthyroidism, adrenal tumors, etc.

More

Featured Medical Technology

SYSMH is the earliest university-affiliated teaching hospital in Guangdong Province to initiate interventional radiology diagnosis and treatment. The Interventional Radiology Subspecialty was officially established in September 2001. Currently, it serves as an integral component of the hospital's National Key Discipline in Oncology, the South China Center for Enhanced Diagnosis and Treatment of Complex and Severe Tumor Diseases, and the Guangdong Provincial Precision Tumor Therapy Center. It is also a core member unit of the National Clinical Research Center for Radiology and Therapeutics specializing in oncology intervention and comprehensive interventional therapy. The department has implemented a wide range of advanced interventional treatment technologies in neurointervention, vascular intervention, and comprehensive intervention, aligning with both domestic and international cutting-edge standards.
The department operates within a comprehensive medical system consisting of an interventional outpatient clinic, an interventional ward, and interventional operating rooms. Currently, it employs 12 full-time physicians and maintains 30 inpatient beds. The interventional operating rooms are equipped with the latest digital subtraction angiography (DSA) systems, large-scale ultrasound devices, and a comprehensive array of minimally invasive interventional equipment for tumor treatment, including microwave ablation, radiofrequency ablation, argon-helium cryoablation, nanoknife ablation, radioactive seed implantation, tumor ablation planning navigation systems, and precision tumor embolization navigation systems.
The department holds a leading position in South China for the comprehensive interventional treatment of solid tumors, such as hepatocellular carcinoma and lung cancer, utilizing various interventional techniques. In the field of vascular disease intervention, it has implemented a full spectrum of diagnostic and therapeutic technologies, including angiography, embolization, thrombolysis, stroke thrombectomy, balloon angioplasty, and stent placement. It has developed distinctive expertise and achieved nationally advanced levels in the interventional management of oral and maxillofacial hemangiomas, hypervascular skull base lesions, comprehensive interventional treatment for deep vein thrombosis with stenosis in the lower limbs, and integrated interventional therapies for portal hypertension and Budd-Chiari syndrome.
In recent years, our department has been among the pioneers in China to conduct clinical research on image-guided nanoknife ablation for locally advanced pancreatic cancer and hepatocellular carcinoma in special anatomical locations, establishing a leading domestic position in treating tumors in complex regions. Since its founding, the department has accumulated extensive clinical experience in localized minimally invasive ablation therapies for various solid tumors. It excels particularly in managing complex and challenging cases, maintaining a nationally advanced level in the comprehensive interventional treatment of solid tumors.

More

Scientific Research Results

SYSMH is the earliest university-affiliated teaching hospital in Guangdong Province to initiate interventional radiology diagnosis and treatment. The Interventional Radiology Subspecialty was officially established in September 2001. Currently, it serves as an integral component of the hospital's National Key Discipline in Oncology, the South China Center for Enhanced Diagnosis and Treatment of Complex and Severe Tumor Diseases, and the Guangdong Provincial Precision Tumor Therapy Center. It is also a core member unit of the National Clinical Research Center for Radiology and Therapeutics specializing in oncology intervention and comprehensive interventional therapy. The department has implemented a wide range of advanced interventional treatment technologies in neurointervention, vascular intervention, and comprehensive intervention, aligning with both domestic and international cutting-edge standards.
The department operates within a comprehensive medical system consisting of an interventional outpatient clinic, an interventional ward, and interventional operating rooms. Currently, it employs 12 full-time physicians and maintains 30 inpatient beds. The interventional operating rooms are equipped with the latest digital subtraction angiography (DSA) systems, large-scale ultrasound devices, and a comprehensive array of minimally invasive interventional equipment for tumor treatment, including microwave ablation, radiofrequency ablation, argon-helium cryoablation, nanoknife ablation, radioactive seed implantation, tumor ablation planning navigation systems, and precision tumor embolization navigation systems.
The department holds a leading position in South China for the comprehensive interventional treatment of solid tumors, such as hepatocellular carcinoma and lung cancer, utilizing various interventional techniques. In the field of vascular disease intervention, it has implemented a full spectrum of diagnostic and therapeutic technologies, including angiography, embolization, thrombolysis, stroke thrombectomy, balloon angioplasty, and stent placement. It has developed distinctive expertise and achieved nationally advanced levels in the interventional management of oral and maxillofacial hemangiomas, hypervascular skull base lesions, comprehensive interventional treatment for deep vein thrombosis with stenosis in the lower limbs, and integrated interventional therapies for portal hypertension and Budd-Chiari syndrome.
In recent years, our department has been among the pioneers in China to conduct clinical research on image-guided nanoknife ablation for locally advanced pancreatic cancer and hepatocellular carcinoma in special anatomical locations, establishing a leading domestic position in treating tumors in complex regions. Since its founding, the department has accumulated extensive clinical experience in localized minimally invasive ablation therapies for various solid tumors. It excels particularly in managing complex and challenging cases, maintaining a nationally advanced level in the comprehensive interventional treatment of solid tumors.

More